Sage Therapeutics, Inc. Annual Depreciation in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sage Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from 2013 to 2024.
  • Sage Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $336K, a 4.03% increase year-over-year.
  • Sage Therapeutics, Inc. annual Depreciation for 2024 was $1.03M, a 26% decline from 2023.
  • Sage Therapeutics, Inc. annual Depreciation for 2023 was $1.39M, a 24.2% increase from 2022.
  • Sage Therapeutics, Inc. annual Depreciation for 2022 was $1.12M, a 73.2% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.03M -$362K -26% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-11
2023 $1.39M +$271K +24.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-11
2022 $1.12M -$3.06M -73.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-11
2021 $4.18M +$1.55M +59% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 $2.63M +$347K +15.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $2.28M +$1.14M +99.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $1.14M +$612K +115% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $531K +$250K +89% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $281K +$166K +144% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 $115K +$64K +125% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $51K +$4K +8.51% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-24
2013 $47K Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.